PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis
USA - NASDAQ:PHLT - US71377E1055 - Common Stock
7.75 USD
+0.02 (+0.26%)
7.75 USD
0 (0%)
Overall PHLT gets a fundamental rating of 3 out of 10. We evaluated PHLT against 100 industry peers in the Health Care Providers & Services industry. The financial health of PHLT is average, but there are quite some concerns on its profitability. PHLT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PHLT had negative earnings in the past year.
In the past year PHLT had a positive cash flow from operations.
PHLT had negative earnings in each of the past 5 years.
Of the past 5 years PHLT 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of PHLT (-0.80%) is comparable to the rest of the industry.
The Return On Equity of PHLT (-1.08%) is comparable to the rest of the industry.
The Return On Invested Capital of PHLT (0.19%) is worse than 60.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.8% | ||
| ROE | -1.08% | ||
| ROIC | 0.19% |
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHLT's Operating Margin of 0.16% is on the low side compared to the rest of the industry. PHLT is outperformed by 60.40% of its industry peers.
The Profit Margin and Gross Margin are not available for PHLT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.16% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PHLT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PHLT has more shares outstanding than it did 1 year ago.
PHLT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PHLT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 13.67 indicates that PHLT is not in any danger for bankruptcy at the moment.
PHLT has a better Altman-Z score (13.67) than 95.05% of its industry peers.
PHLT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.10, PHLT is in the better half of the industry, outperforming 77.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.67 |
ROIC/WACC0.02
WACC9.27%
2.3 Liquidity
PHLT has a Current Ratio of 2.64. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PHLT (2.64) is better than 82.18% of its industry peers.
A Quick Ratio of 2.64 indicates that PHLT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.64, PHLT belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.64 | ||
| Quick Ratio | 2.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 87.50% over the past year.
Looking at the last year, PHLT shows a quite strong growth in Revenue. The Revenue has grown by 15.21% in the last year.
PHLT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.95% yearly.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%
3.2 Future
Based on estimates for the next years, PHLT will show a very strong growth in Earnings Per Share. The EPS will grow by 50.55% on average per year.
Based on estimates for the next years, PHLT will show a quite strong growth in Revenue. The Revenue will grow by 11.37% on average per year.
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 103.61 indicates a quite expensive valuation of PHLT.
PHLT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PHLT is more expensive than 60.40% of the companies in the same industry.
PHLT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.62.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 103.61 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHLT is valued a bit more expensive than the industry average as 62.38% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 96.91 |
4.3 Compensation for Growth
PHLT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PHLT's earnings are expected to grow with 50.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.48%
EPS Next 3Y50.55%
5. Dividend
5.1 Amount
PHLT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.75
+0.02 (+0.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.43%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner ChangeN/A
Market Cap623.41M
Revenue(TTM)137.36M
Net Income(TTM)-885.00K
Analysts48.89
Price Target7.91 (2.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)188.22%
Min EPS beat(2)100%
Max EPS beat(2)276.44%
EPS beat(4)4
Avg EPS beat(4)104.9%
Min EPS beat(4)1.96%
Max EPS beat(4)276.44%
EPS beat(8)8
Avg EPS beat(8)102.34%
EPS beat(12)11
Avg EPS beat(12)79.64%
EPS beat(16)14
Avg EPS beat(16)64.19%
Revenue beat(2)2
Avg Revenue beat(2)10.95%
Min Revenue beat(2)9%
Max Revenue beat(2)12.91%
Revenue beat(4)2
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)12.91%
Revenue beat(8)6
Avg Revenue beat(8)3.99%
Revenue beat(12)7
Avg Revenue beat(12)1.42%
Revenue beat(16)10
Avg Revenue beat(16)2.44%
PT rev (1m)0%
PT rev (3m)6.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-300.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-188.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 103.61 | ||
| P/S | 4.54 | ||
| P/FCF | N/A | ||
| P/OCF | 129.71 | ||
| P/B | 7.58 | ||
| P/tB | 17.88 | ||
| EV/EBITDA | 96.91 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY0.97%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.06
OCFY0.77%
SpS1.71
BVpS1.02
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.8% | ||
| ROE | -1.08% | ||
| ROCE | 0.24% | ||
| ROIC | 0.19% | ||
| ROICexc | 0.21% | ||
| ROICexgc | 0.48% | ||
| OM | 0.16% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.25 | ||
| Cap/Depr | 84.63% | ||
| Cap/Sales | 3.82% | ||
| Interest Coverage | 0.27 | ||
| Cash Conversion | 74.84% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.64 | ||
| Quick Ratio | 2.64 | ||
| Altman-Z | 13.67 |
F-Score6
WACC9.27%
ROIC/WACC0.02
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y104.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.29%
EBIT Next 3Y72.41%
EBIT Next 5YN/A
FCF growth 1Y-183.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.31%
OCF growth 3Y88.66%
OCF growth 5YN/A
PERFORMANT HEALTHCARE INC / PHLT FAQ
What is the ChartMill fundamental rating of PERFORMANT HEALTHCARE INC (PHLT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PHLT.
What is the valuation status of PERFORMANT HEALTHCARE INC (PHLT) stock?
ChartMill assigns a valuation rating of 1 / 10 to PERFORMANT HEALTHCARE INC (PHLT). This can be considered as Overvalued.
How profitable is PERFORMANT HEALTHCARE INC (PHLT) stock?
PERFORMANT HEALTHCARE INC (PHLT) has a profitability rating of 1 / 10.
Can you provide the financial health for PHLT stock?
The financial health rating of PERFORMANT HEALTHCARE INC (PHLT) is 6 / 10.
What is the expected EPS growth for PERFORMANT HEALTHCARE INC (PHLT) stock?
The Earnings per Share (EPS) of PERFORMANT HEALTHCARE INC (PHLT) is expected to grow by 89.54% in the next year.